1. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
   Xiuting Liu et al, 2018, Int J Cancer CrossRef
2. A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem
   Yujuan Zhang et al, 2018, Int. J. Cancer CrossRef
3. What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?
   Theodoros Eleftheriadis, 2018, Front. Immunol. CrossRef
4. Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity
   Yujuan Zhang et al, 2020, Front. Immunol. CrossRef
5. Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines
   Sara Paccosi et al, 2020, J Cancer Res Clin Oncol CrossRef
6. Not Only Immune Escape—The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis
   Iwona Kwiatkowska et al, 2021, Cancers CrossRef
7. Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
   Xiaotian Song et al, 2021, Front. Immunol. CrossRef
8. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer
   Xinlong Zang et al, 2022, J. Mater. Chem. B CrossRef
9. The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment
   Xinting Huang et al, 2022, Cancers CrossRef
10. IDO/kynurenine pathway in cancer: possible therapeutic approaches
    Eslam E. Abd El-Fattah, 2022, J Transl Med CrossRef
11. Self‐Splittable Transcytosis Nanoraspberry for NIR‐II Photo‐Immunometabolic Cancer Therapy in Deep Tumor Tissue
    Li Wang et al, 2022, Advanced Science CrossRef
12. Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer
    Longbo Yu et al, 2022, International Immunopharmacology CrossRef
13. The exploitation of enzyme-based cancer immunotherapy
    Gourav Chandan et al, 2022, Human Cell CrossRef
14. Effects of gene silencing of indoleamine 2,3-dioxygenase 1 combined with rosmarinic acid on tumor immune microenvironment in H22 tumor-bearing mice
    Wen Cao et al, 2023, International Immunopharmacology CrossRef